The life sciences industry is constantly changing, evolving, and expanding, and keeping up to date can be challenging. Here on our blog, our life science industry experts regularly post articles pertaining to a wide range of industry trends and concerns, enabling you to benefit from our trusted knowledge. Below are our latest life science articles.
How Metrics Can Help Identify and Solve Operational Challenges
Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of
Growth by Acquisition in Life Sciences: Do You Have a Plan?
Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as
R&D Revolutionaries: Why the Actavis/Allergan Deal Takes a Stand for Biopharma’s True Roots in Innovation
James Forte of Kineticos takes an in-depth look at the recent Actavis/Allergan deal including the role R&D innovation played in shaping the deal’s outcome. Let’s be candid. It’s been awhile since any biopharma company was able to claim R&D as a core competency with a straight face. Biopharma’s R&D efforts have long been challenged, and rightly so given its output, but the Actavis/Allergan deal shows that the right investment in R&D can revolutionize a business. Could efficient R&D be the new definition of innovation?
Driving Revenue and EBIDTA at CROs through Customer Loyalty
Article Preview Determining customer satisfaction and loyalty is a difficult endeavor for most businesses. Traditional voice of customer surveys are
Merck KGaA and Bayer Choose Opposite Strategies
Article Preview Europe’s two largest chemical and drug conglomerates are changing course in starkly opposite ways. As reported in recent
Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships
Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping
Foundation Medicine and Clovis Expand Partnership
Article Preview In April 2014, Foundation Medicine and Clovis Oncology announced the expansion of their partnership by developing a companion
Role of Companion Diagnostics in Immuno-oncology Race Unfolding
Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies
Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth
Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based
LabCorp to Acquire LipoScience
Article Preview Laboratory Corporation of America Holdings is making a strong bid to expand its personalized medicine offering by adding